Gan & Lee Pharmaceuticals. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 2,596.44 million compared to CNY 1,709.87 million a year ago.

Revenue was CNY 2,608.04 million compared to CNY 1,712.27 million a year ago. Net income was CNY 340.07 million compared to net loss of CNY 439.52 million a year ago. Basic earnings per share from continuing operations was CNY 0.6 compared to basic loss per share from continuing operations of CNY 0.78 a year ago.

Diluted earnings per share from continuing operations was CNY 0.6 compared to diluted loss per share from continuing operations of CNY 0.78 a year ago.